Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register

Pharma Stories, Blogs, Interviews & Press Releases

WHO Opens Prequalification for Childhood Cancer and Opioid Medicines: What Manufacturers Should Know
WHO Opens Prequalification for Childhood Cancer and Opioid Medicines: What Manufacturers Should Know

By the PharmaTradz BD Team. Published October 2026. In the space of four months, WHO has opened its prequalification pro...

Read Full Story
The EU Pharma Package and Generic Launches: What Changes for Generic and Biosimilar Companies
The EU Pharma Package and Generic Launches: What Changes for Generic and Biosimilar Companies

By the PharmaTradz BD Team. Published October 2026. Europe's medicines law is about to change for the first time in more...

Read Full Story
US Tariffs on Generic Medicines from 2028: What Buyers and Exporters Should Plan for Now
US Tariffs on Generic Medicines from 2028: What Buyers and Exporters Should Plan for Now

By the PharmaTradz BD Team. Published October 2026. In July, the US President announced on social media that imported ge...

Read Full Story
How to Choose a CDMO in Europe: EU-GMP Licences, QP Release and What to Check (2026)
How to Choose a CDMO in Europe: EU-GMP Licences, QP Release and What to Check (2026)

By the PharmaTradz BD Team. Published October 2026. People searching for a contract manufacturer in Europe often type th...

Read Full Story
US Pharma Tariffs Three Weeks In: What API and Finished-Dose Buyers Need to Know
US Pharma Tariffs Three Weeks In: What API and Finished-Dose Buyers Need to Know

By the PharmaTradz BD Team. Published October 2026. The US tariff on patented medicines has now applied to every importe...

Read Full Story
The Netherlands Moves to Restrict Ashwagandha: What Supplement Exporters Should Do Now
The Netherlands Moves to Restrict Ashwagandha: What Supplement Exporters Should Do Now

By the PharmaTradz BD Team. Published October 2026. Ashwagandha is one of the best-selling botanicals of the decade. It...

Read Full Story
October's New US Drug Shortages: Where Licensed Suppliers Can Step In
October's New US Drug Shortages: Where Licensed Suppliers Can Step In

By the PharmaTradz BD Team. Published October 2026. Every few weeks, a new set of medicines goes on the US shortage list...

Read Full Story
Nitrosamines After CPHI Milan 2026: What Buyers Should Ask For in a Dossier
Nitrosamines After CPHI Milan 2026: What Buyers Should Ask For in a Dossier

By the PharmaTradz BD Team. Published October 2026. Nitrosamines have been on regulators' lists since 2018, and the form...

Read Full Story
FDA's Proposed Mandatory GRAS Rule: What Ingredient Suppliers Should Do Now
FDA's Proposed Mandatory GRAS Rule: What Ingredient Suppliers Should Do Now

By the PharmaTradz BD Team. Published October 2026. On 11 August 2026, the US Food and Drug Administration proposed maki...

Read Full Story
Generic Semaglutide Six Months On: What the First Markets Taught Buyers
Generic Semaglutide Six Months On: What the First Markets Taught Buyers

By the PharmaTradz BD Team. Published October 2026. Six months after semaglutide's core patent expired on 20 March 2026,...

Read Full Story
Why the Same Medicine Has Different Brand Names in Different Countries
Why the Same Medicine Has Different Brand Names in Different Countries

By the PharmaTradz BD Team. Published October 2026. The same medicine often carries different brand names in different c...

Read Full Story
日本・韓国・オーストラリア・ニュージーランドへの医薬品輸入ガイド(2026年)
日本・韓国・オーストラリア・ニュージーランドへの医薬品輸入ガイド(2026年)

最終更新:2026年10月10日。地域別医薬品輸入ガイドシリーズの日本語版です。日本、韓国、オーストラリア、ニュージーランドを扱...

Read Full Story

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us